Celebrate Pi Day and read all about how this number pops up across math and science on our special Pi Day page. Grab something circular, like a cup, measure the distance around the circle, and divide ...

mCOMBRIAX is the world’s first flu plus COVID combination vaccine to receive a positive CHMP opinion recommending marketing authorization and represents Moderna’s fourth vaccine to receive a positive ...

Wondering how to open the locker in Resident Evil Requiem? As part of Barry's scavenger hunt, he gives you a couple of clues on where to find the hidden treasure. Solving this gives you the keys to ...

A phase 1 dose escalation study of a novel coupled CAR T cell therapy, GCC19CART, for patients with metastatic colorectal cancer. A new prognostic tool for metastatic colorectal cancer patients ...

With scour being the biggest killer of young calves on dairy farms in Ireland, farmers have reason for concern of outbreaks this calving season. Studies estimate that scour can cost between €150–€190 ...

In patients with HIV infection, the use of opioids alone was not associated with reduced cognition or depressive mood, whereas the combined use of opioids, antidepressants, and statins or ...

You can approach heart rate training in a few ways, and each method has its own set of variables. It can seem like a complicated process. That’s why whenever heart rate training entered the chat, I ...

Amateur mathematicians are using artificial intelligence chatbots to solve long-standing problems, in a move that has taken professionals by surprise. While the problems in question aren’t the most ...

Nahda Nabiilah is a writer and editor from Indonesia. She has always loved writing and playing games, so one day she decided to combine the two. Most of the time, writing gaming guides is a blast for ...

Ramanujan’s elegant formulas for calculating pi, developed more than a century ago, have unexpectedly resurfaced at the heart of modern physics. Researchers at IISc discovered that the same ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced positive topline results from the Phase 3 ARTISTRY-2 trial. The double-blind trial evaluated the treatment ...